Our results demonstrate that QDHXY suppresses inflammation by enhancing eNOS expression and inhibiting the expression of caveolin-1 and MyD88, which might facilitate its clinical applications in the management of ALI. Here, CAV1 is linked to acute respiratory distress syndrome.